Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1999; 82(05): 1558-1559
DOI: 10.1055/s-0037-1614877
DOI: 10.1055/s-0037-1614877
Letters to the Editor
A Case of Type 2B von Willebrand Disease Reverse to Normal when Treated with High Doses of Protease Inhibitor
Authors
Further Information
Publication History
Received
05 May 1999
Accepted after revision
07 July 1999
Publication Date:
09 December 2017 (online)
-
References
- 1 Ginsberg D, Sadler JE. VWD a database of point mutations, insertions and deletions. Thromb Haemost 1993; 69: 177-84.
- 2 Verweij CL, Quadt R, Briet E, Dubbledam K, van Ommen GB, Pannekoek H. Genetic linkage of two intragenic restriction fragment length polymorphisms with vWD type IIA. J Clin Invest 1988; 81: 1116-21.
- 3 Lyons SE, Bruck ME, Bowie EJW, Ginsberg D. Impaired intracellular transport produced by a subset of type IIA vWD mutations. J Biol Chem 1992; 267: 4424-30.
- 4 Gaucher C, Dieval J, Mazurier C. Characterization of vWF gene defect in two unrelated patients with type IIC vWD. Blood 1994; 84: 1024-30.
- 5 Gralnick HR, Williams SB, McKeown LP, Maisonneuve P, Jenneau C, Sultan Y. A variant of type II vWD with an abnormal triplet structure and discordant effects of protease inhibitor on plasma and platelet vW factor structure. Amer J Hematol 1987; 24: 259-66.
- 6 Cooney KA, Nichols W, Bruck M, Bahou W, Shapiro A, Bowie EJW, Gralnick H, Ginsberg D. The molecular defect in type IIB vWD. J Clin Invest 1991; 87: 1227-33.
- 7 Arkel Y, Desposito F. vWD with thrombocytopenia, platelet function defect and an abnormal factor VIII/vWF. Am J Ped Hematol/Oncol 1982; 4: 249-57.